2
Clinical Trials associated with Xuezhitai Dispersible Tablets血脂泰分散片治疗高脂血症(痰浊阻遏证)的随机、双盲、阳性药对照、多中心临床试验
[Translation] A randomized, double-blind, positive drug-controlled, multicenter clinical trial of Xuezhitai dispersible tablets in the treatment of hyperlipidemia (phlegm-turbidity obstruction syndrome)
以阿托伐他汀钙片为阳性对照,探索血脂泰分散片治疗高脂血症(痰浊阻遏)的有效性和安全性。
[Translation] Using atorvastatin calcium tablets as a positive control, the efficacy and safety of Xuezhitai dispersible tablets in the treatment of hyperlipidemia (phlegm and turbidity inhibition) were explored.
[Translation] Phase I clinical human tolerance trial plan for Xuezhitai dispersible tablets
选择健康人为受试者,从安全的初始剂量开始,通过对健康受试者进行血脂泰分散片不同给药剂量的探索,考察人体的耐受性和安全性,为Ⅱ期临床试验提供安全的剂量范围。
[Translation] Healthy subjects were selected as subjects, starting from a safe initial dose, and different dosages of Xuezhitai Dispersible Tablets were explored on healthy subjects to examine the human body's tolerance and safety, providing a safe dosage range for Phase II clinical trials.
100 Clinical Results associated with Xuezhitai Dispersible Tablets
100 Translational Medicine associated with Xuezhitai Dispersible Tablets
100 Patents (Medical) associated with Xuezhitai Dispersible Tablets
100 Deals associated with Xuezhitai Dispersible Tablets